'Maze Runner: The Dead Cure': An entertaining wrap-up of the series (IANS Review, Rating: ***)

Image
IANS
Last Updated : Feb 02 2018 | 6:41 PM IST

Film: "Maze Runner: The Dead Cure"; Director: Wes Ball; Cast:Dylan O'Brien, Thomas Brodie-Sangster, Kaya Scodelario, Giancarlo Esposito, Rosa Salazar, Aidan Gillen, Walton Goggins, Ki Hong Lee, Barry Pepper, Will Poulter, Patricia Clarkson; Rating: ***

"Maze Runner: The Death Cure" is the third edition of the series and is a breeze for those who are initiated into it.

For those who are new to the series, the screenplay written by T.S. Nowlin based on "The Maze Runner" novels by the American author James Dashner, is directed by Wes Ball. This edition picks up roughly six months after its 2015 predecessor, "Maze Runner: The Scorch Trials", left off.

Set in the distant future, in a dystopian state, the narrative begins with an excitingly staged, action-packed, multi-prong assault on a train that seems like a great train robbery. The perpetrators are the last of the Gladers. If you have to ask who they are, then you haven't seen the first two films.

They include Thomas (O'Brien) and his cohorts Frypan (Dexter Darden), Newt (Thomas Brodie-Sangster) and their fellow resistance fighters Jorge (Giancarlo Esposito) and Brenda (Rosa Salazar).

Their target is to rescue their friend Minho who is in the coach filled with children being sent to the Lost City, WCKD headquarters. Minho and the other children are being sent to a research facility where scientists will sacrifice them in the hope of using their blood to find a cure for "The Flare", a plague that turns people into zombies referred to as "Cranks".

This plague is ravaging what is left of humanity and as one of the characters said, "It's amazing what people can do when their survival is at stake."

The plot is entertaining without a doubt. There are plenty of big-budget action stunts, explosions and intense shootouts like you would expect. It ties up loose ends and finds a way to close out the series in a surprisingly emotional send-off.

That apart, there are plenty of misgivings sprinkled into the mix. First of all, the amount of deus-ex-machina in the film makes the entire process seem too predictable and boring at times. Secondly, the scenes are unnecessarily lengthy. And thirdly, the plot folds within itself many times, making the entire process a bit tedious.

A case in point is the initial goal to recuse Minho. As soon as they nearly achieve this, we are told Newt is infected and getting the serum for him becomes the priority, followed by Teresa's revelations.

And most of all, in the action sequences, except for a stray bullet that hits Thomas the large army of Stormtroopers are pretty ineffective in capturing the opponents, only speaks poorly of them or the director.

The film features many of the same characters from its predecessors. And the performers all seem to have effectively grown into their characters. Each one of them have their moments of on-screen glory and they all shine.

Overall, this film is a wrap up tale of the previous two editions and thus will appeal only to fans of the series. Others will find this film a slog.

--IANS

troy/rb/bg

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 02 2018 | 6:34 PM IST

Next Story